Impact of the Requirement of Bone Mineral Density Evidence on Utilization of Anti-osteoporosis Medications, Clinical Outcome and Medical Expenditures of Patient With Hip Fracture in Taiwan

• Hauptverfasser: Chen-Yu Wang (Verfasst von), Shau-Huai Fu (Verfasst von), Chih-Chien Hung (Verfasst von), Rong-Sen Yang (Verfasst von), Jou-Wei Lin (Verfasst von), Ho-Min Chen (Verfasst von), Fei-Yuan Hsiao (Verfasst von), Li-Jiuan Shen (Verfasst von)
• Format: Buch
• Veröffentlicht: Kerman University of Medical Sciences, 2022-04-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

BackgroundSince 2011, Taiwan's National Health Insurance Administration (NHIA) issued a regulation on the reimbursement to anti-osteoporosis medications (AOMs). This study aimed to evaluate the impact of this regulation in reimbursement on the utilization of AOMs, clinical outcomes and associat...